Physician profile
Michael B Bauer
NPI 1497799977
$486.91
in general payments reported to CMS, 2019-2025
10 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.00 · 2020: $99.95 · 2021: $25.57 · 2022: $32.90 · 2023: $12.80 · 2024: $117 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $141.52 | 2021-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $129.19 | 2020-2023 | Myrbetriq |
| Pfizer INC. | $48.46 | 2024-2025 | |
| Endo USA, INC. | $40.93 | 2024-2025 | Xiaflex |
| Sumitomo Pharma America, INC. | $27.96 | 2024 | Orgovyx |
| Olympus America INC. | $26.18 | 2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $24.20 | 2025 | |
| Cook Biotech Incorporated | $20.00 | 2019 | |
| Abbvie INC. | $16.46 | 2022 | |
| Urogen Pharma, INC. | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.